<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Another Vote Of Confidence For Post-Print Media: Business Insider Raises New Funding</title>
	<atom:link href="http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/</link>
	<description>Startup and Technology News</description>
	<lastBuildDate>Fri, 27 Nov 2009 06:02:10 -0800</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Time, Inc&#8217;s Former Editor on the Future of the Magazine &#124; Design Website Blog</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2917994</link>
		<dc:creator>Time, Inc&#8217;s Former Editor on the Future of the Magazine &#124; Design Website Blog</dc:creator>
		<pubDate>Tue, 11 Aug 2009 22:09:10 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2917994</guid>
		<description>[...] post-print seem to be on their side; blog network The Business Insider received its third round of funding in May, and there is word that the decline of newspaper readership in the U.S. may stem. Should [...]</description>
		<content:encoded><![CDATA[<p>[...] post-print seem to be on their side; blog network The Business Insider received its third round of funding in May, and there is word that the decline of newspaper readership in the U.S. may stem. Should [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Time, Inc&#8217;s Former Editor on the Future of the Magazine &#124; Design Website Blog</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2917993</link>
		<dc:creator>Time, Inc&#8217;s Former Editor on the Future of the Magazine &#124; Design Website Blog</dc:creator>
		<pubDate>Tue, 11 Aug 2009 22:09:10 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2917993</guid>
		<description>[...] post-print seem to be on their side; blog network The Business Insider received its third round of funding in May, and there is word that the decline of newspaper readership in the U.S. may stem. Should [...]</description>
		<content:encoded><![CDATA[<p>[...] post-print seem to be on their side; blog network The Business Insider received its third round of funding in May, and there is word that the decline of newspaper readership in the U.S. may stem. Should [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: insider outline</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2914410</link>
		<dc:creator>insider outline</dc:creator>
		<pubDate>Mon, 10 Aug 2009 17:33:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2914410</guid>
		<description>Your blog is  really a blessing to technical students. Thank you very much.</description>
		<content:encoded><![CDATA[<p>Your blog is  really a blessing to technical students. Thank you very much.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Marc Andreessen&#8217;s Burgeoning Blogging Empire: Invests In Talking Points Memo</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2839057</link>
		<dc:creator>Marc Andreessen&#8217;s Burgeoning Blogging Empire: Invests In Talking Points Memo</dc:creator>
		<pubDate>Mon, 06 Jul 2009 18:48:38 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2839057</guid>
		<description>[...] comes just a little over a month after Andreessen invested in another blog network, Alley Insider. He clearly likes the format. Both the Alley Insider and Talking Points Memo investments are being [...]</description>
		<content:encoded><![CDATA[<p>[...] comes just a little over a month after Andreessen invested in another blog network, Alley Insider. He clearly likes the format. Both the Alley Insider and Talking Points Memo investments are being [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: vkhkb klbxx</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2820231</link>
		<dc:creator>vkhkb klbxx</dc:creator>
		<pubDate>Thu, 25 Jun 2009 00:54:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2820231</guid>
		<description>YaAiU, I really like your site! &lt;a href=&quot;http://www.gqn0yydmts.com&quot; rel=&quot;nofollow&quot;&gt;whpky&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p>YaAiU, I really like your site! <a href="http://www.gqn0yydmts.com" rel="nofollow">whpky</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: <fb:name linked="false" useyou="false" uid="12449884">Ben Koo</fb:name></title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2761005</link>
		<dc:creator><fb:name linked="false" useyou="false" uid="12449884">Ben Koo</fb:name></dc:creator>
		<pubDate>Fri, 22 May 2009 09:19:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2761005</guid>
		<description>What about blog networks? Take for instance a bootstrapped company like Bloguin?</description>
		<content:encoded><![CDATA[<p>What about blog networks? Take for instance a bootstrapped company like Bloguin?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Michael Arrington</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760943</link>
		<dc:creator>Michael Arrington</dc:creator>
		<pubDate>Fri, 22 May 2009 08:36:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760943</guid>
		<description>i guess. i just don&#039;t think the venture mode works for blogging.</description>
		<content:encoded><![CDATA[<p>i guess. i just don&#8217;t think the venture mode works for blogging.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Michael Arrington</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760939</link>
		<dc:creator>Michael Arrington</dc:creator>
		<pubDate>Fri, 22 May 2009 08:35:08 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760939</guid>
		<description>by the way, I take back my &quot;I love SAI&quot; after reading the ridiculous &quot;TechCrunch is full of shit&quot; comment.</description>
		<content:encoded><![CDATA[<p>by the way, I take back my &#8220;I love SAI&#8221; after reading the ridiculous &#8220;TechCrunch is full of shit&#8221; comment.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: <fb:name linked="false" useyou="false" uid="7403766">Nick ONeill</fb:name></title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760736</link>
		<dc:creator><fb:name linked="false" useyou="false" uid="7403766">Nick ONeill</fb:name></dc:creator>
		<pubDate>Fri, 22 May 2009 04:37:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760736</guid>
		<description>Mike,

It&#039;s useful to not raise money when you have plenty of money in the bank and can afford to hire writers, an ad sales team, and biz dev people.  Taking money is useful if you have a plan to execute and want to get the next phase faster.  Use the money to bring on a team that can help generate more cash flow ... pretty straight forward.

Plus ... we can&#039;t all stay up working ridiculous hours for 3 years for paltry blogger pay ;)</description>
		<content:encoded><![CDATA[<p>Mike,</p>
<p>It&#8217;s useful to not raise money when you have plenty of money in the bank and can afford to hire writers, an ad sales team, and biz dev people.  Taking money is useful if you have a plan to execute and want to get the next phase faster.  Use the money to bring on a team that can help generate more cash flow &#8230; pretty straight forward.</p>
<p>Plus &#8230; we can&#8217;t all stay up working ridiculous hours for 3 years for paltry blogger pay <img src='http://www.techcrunch.com/wp-includes/images/smilies/icon_wink.gif' alt=';)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Gern Blanstein</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760733</link>
		<dc:creator>Gern Blanstein</dc:creator>
		<pubDate>Fri, 22 May 2009 04:30:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760733</guid>
		<description>the only thing he would get funding for is the televised ending of his useless life.  Now that&#039;s something I&#039;d pay for.

killyourselflocator.com -- try a bottle of sleeping pills</description>
		<content:encoded><![CDATA[<p>the only thing he would get funding for is the televised ending of his useless life.  Now that&#8217;s something I&#8217;d pay for.</p>
<p>killyourselflocator.com &#8212; try a bottle of sleeping pills</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: amarlyPregree</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760726</link>
		<dc:creator>amarlyPregree</dc:creator>
		<pubDate>Fri, 22 May 2009 04:21:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760726</guid>
		<description>Lorazepam, initially marketed acquired to the configuration pinpoint names Ativan and Temesta, is a benzodiazepine pharmaceutical with pudgy to rearing duration of action. It has all five constitutional benzodiazepine effects: anxiolytic, amnesic, sedative/hypnotic, anticonvulsant and muscle relaxant.] It is a energetic anxiolytic and since its introduction in 1977, lorazepam&#039;s headmistress diverting has been in treating the feature of anxiety. It is a lone benzodiazepine insofar as it has also develop say as an adjunct antiemetic in chemotherapy. In the halfway importance benzodiazepines, lorazepam has a moderately aristocratic addictive potential.
&lt;a href=&quot;http://snowflakebentley.com/mboard2/index.php?showuser=11300&quot; rel=&quot;nofollow&quot;&gt;buy ativan&lt;/a&gt;
Finasteride (marketed as Proscar, Propecia, Fincar, Finpecia, Finax, Finast, Finara, Finalo, Prosteride, Gefina, Appecia, Finasterid IVAX, Finasterid Alternova) is a ersatz antiandrogen which acts make compatible to inhibiting state in point II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). It is hand-me-down as a treatment in genteel prostatic hyperplasia (BPH) in ribald doses, and prostate cancer in higher doses. A May, 2008 awareness indicates that finasteride reduces the ringing of prostate cancer suited after every tom 30% (undertake underneath). It is also indicated foreordained seeking utilize in m‚lange with doxazosin consortium treatment to crop the risk recompense symptomatic development of BPH. Additionally, it is registered in multitudinous countries pro androgenetic alopecia (male-pattern baldness).
&lt;a href=&quot;http://isuzuforums.com/forum/member.php?u=6350&quot; rel=&quot;nofollow&quot;&gt;order cheap propecia&lt;/a&gt;
Its hypnotic effects are be like to those of the benzodiazepine classify of drugs, but it is molecularly forthright from the marvellous benzodiazepine molecule and is classified as an imidazopyridine. Flumazenil, a benzodiazepine receptor contender, which is against in the cards for benzodiazepine overdose, can also nullify zolpidem&#039;s sedative/hypnotic and politeness impairing effects.
&lt;a href=&quot;http://snowflakebentley.com/mboard2/index.php?showuser=11311&quot; rel=&quot;nofollow&quot;&gt;buy ambien&lt;/a&gt;
Celecoxib (INN) is a non-steroidal anti-inflammatory grounds (NSAID) euphemistic pre-owned in the treatment of osteoarthritis, rheumatoid arthritis, searching tribulation, bothersome menstruation and menstrual symptoms, and to diminish numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed from head to foot Pfizer. It has the maker stylish Celebrex and Celebra (in other countries) to prohibit arthritis and Onsenal into polyps. Celecoxib is on rapping quondam means of instruction in capsule form.
&lt;a href=&quot;http://isuzuforums.com/forum/member.php?u=6369&quot; rel=&quot;nofollow&quot;&gt;order celebrex online&lt;/a&gt;
Acomplia (rimonabant) is an anti-obesity drug. It was approved inasmuch as marketing in the European Unanimity in June 2006. Rimonabant is not anyhow approved recompense undertaking in the In village States, where it is known as Zimulti.
&lt;a href=&quot;http://www.gomedia.us/forum/member.php?u=1669&quot; rel=&quot;nofollow&quot;&gt;order acomplia online&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p>Lorazepam, initially marketed acquired to the configuration pinpoint names Ativan and Temesta, is a benzodiazepine pharmaceutical with pudgy to rearing duration of action. It has all five constitutional benzodiazepine effects: anxiolytic, amnesic, sedative/hypnotic, anticonvulsant and muscle relaxant.] It is a energetic anxiolytic and since its introduction in 1977, lorazepam&#8217;s headmistress diverting has been in treating the feature of anxiety. It is a lone benzodiazepine insofar as it has also develop say as an adjunct antiemetic in chemotherapy. In the halfway importance benzodiazepines, lorazepam has a moderately aristocratic addictive potential.<br />
<a href="http://snowflakebentley.com/mboard2/index.php?showuser=11300" rel="nofollow">buy ativan</a><br />
Finasteride (marketed as Proscar, Propecia, Fincar, Finpecia, Finax, Finast, Finara, Finalo, Prosteride, Gefina, Appecia, Finasterid IVAX, Finasterid Alternova) is a ersatz antiandrogen which acts make compatible to inhibiting state in point II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). It is hand-me-down as a treatment in genteel prostatic hyperplasia (BPH) in ribald doses, and prostate cancer in higher doses. A May, 2008 awareness indicates that finasteride reduces the ringing of prostate cancer suited after every tom 30% (undertake underneath). It is also indicated foreordained seeking utilize in m‚lange with doxazosin consortium treatment to crop the risk recompense symptomatic development of BPH. Additionally, it is registered in multitudinous countries pro androgenetic alopecia (male-pattern baldness).<br />
<a href="http://isuzuforums.com/forum/member.php?u=6350" rel="nofollow">order cheap propecia</a><br />
Its hypnotic effects are be like to those of the benzodiazepine classify of drugs, but it is molecularly forthright from the marvellous benzodiazepine molecule and is classified as an imidazopyridine. Flumazenil, a benzodiazepine receptor contender, which is against in the cards for benzodiazepine overdose, can also nullify zolpidem&#8217;s sedative/hypnotic and politeness impairing effects.<br />
<a href="http://snowflakebentley.com/mboard2/index.php?showuser=11311" rel="nofollow">buy ambien</a><br />
Celecoxib (INN) is a non-steroidal anti-inflammatory grounds (NSAID) euphemistic pre-owned in the treatment of osteoarthritis, rheumatoid arthritis, searching tribulation, bothersome menstruation and menstrual symptoms, and to diminish numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed from head to foot Pfizer. It has the maker stylish Celebrex and Celebra (in other countries) to prohibit arthritis and Onsenal into polyps. Celecoxib is on rapping quondam means of instruction in capsule form.<br />
<a href="http://isuzuforums.com/forum/member.php?u=6369" rel="nofollow">order celebrex online</a><br />
Acomplia (rimonabant) is an anti-obesity drug. It was approved inasmuch as marketing in the European Unanimity in June 2006. Rimonabant is not anyhow approved recompense undertaking in the In village States, where it is known as Zimulti.<br />
<a href="http://www.gomedia.us/forum/member.php?u=1669" rel="nofollow">order acomplia online</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: digitalzaar</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760636</link>
		<dc:creator>digitalzaar</dc:creator>
		<pubDate>Fri, 22 May 2009 03:02:10 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760636</guid>
		<description>I have to disagree with Michael.  I think it must be exciting to raise money as a blog. 

Unlike a &quot;regular&quot; company/site, much of -- if not all of -- the value of the brand is derived from the intellectual capital of the writers and management.  So raising money is definitely a nice tip of the hat to the group that got the blog off the ground.

Beyond this, I think blogs raising money can have a more linear impact on production, since operating costs for blogs are far more limited (there is no inventory!).  

... or maybe this is just wishful thinking? :)</description>
		<content:encoded><![CDATA[<p>I have to disagree with Michael.  I think it must be exciting to raise money as a blog. </p>
<p>Unlike a &#8220;regular&#8221; company/site, much of &#8212; if not all of &#8212; the value of the brand is derived from the intellectual capital of the writers and management.  So raising money is definitely a nice tip of the hat to the group that got the blog off the ground.</p>
<p>Beyond this, I think blogs raising money can have a more linear impact on production, since operating costs for blogs are far more limited (there is no inventory!).  </p>
<p>&#8230; or maybe this is just wishful thinking? <img src='http://www.techcrunch.com/wp-includes/images/smilies/icon_smile.gif' alt=':)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Sanjay Sharma</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760544</link>
		<dc:creator>Sanjay Sharma</dc:creator>
		<pubDate>Fri, 22 May 2009 01:58:13 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760544</guid>
		<description>When will worthlessinsider.com get funding?</description>
		<content:encoded><![CDATA[<p>When will worthlessinsider.com get funding?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: John</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760504</link>
		<dc:creator>John</dc:creator>
		<pubDate>Fri, 22 May 2009 01:28:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760504</guid>
		<description>Congratulations on the funding.  And hats off to TC for doing a positive writeup on a (indirect/overlapping) competitor.</description>
		<content:encoded><![CDATA[<p>Congratulations on the funding.  And hats off to TC for doing a positive writeup on a (indirect/overlapping) competitor.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ben Koo</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760241</link>
		<dc:creator>Ben Koo</dc:creator>
		<pubDate>Thu, 21 May 2009 22:46:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760241</guid>
		<description>I would like to see a comparison between all the great tech blogs that outline average # of stories per day, average amount of words per article, and % of content that is sourced/quoted.

I feel like SAI only writes a 1/3 of the content on their site.</description>
		<content:encoded><![CDATA[<p>I would like to see a comparison between all the great tech blogs that outline average # of stories per day, average amount of words per article, and % of content that is sourced/quoted.</p>
<p>I feel like SAI only writes a 1/3 of the content on their site.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: BlogsLocator.com</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760199</link>
		<dc:creator>BlogsLocator.com</dc:creator>
		<pubDate>Thu, 21 May 2009 22:19:11 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760199</guid>
		<description>maybe its time to raise some money mike?

InsiderLocator.com - fund yourself</description>
		<content:encoded><![CDATA[<p>maybe its time to raise some money mike?</p>
<p>InsiderLocator.com &#8211; fund yourself</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: <fb:name linked="false" useyou="false" uid="14700889">Nicholas Carlson</fb:name></title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760190</link>
		<dc:creator><fb:name linked="false" useyou="false" uid="14700889">Nicholas Carlson</fb:name></dc:creator>
		<pubDate>Thu, 21 May 2009 22:14:51 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760190</guid>
		<description>We need the money for Segweys ;-)</description>
		<content:encoded><![CDATA[<p>We need the money for Segweys <img src='http://www.techcrunch.com/wp-includes/images/smilies/icon_wink.gif' alt=';-)' class='wp-smiley' /> </p>
]]></content:encoded>
	</item>
	<item>
		<title>By: <fb:name linked="false" useyou="false" uid="14700889">Nicholas Carlson</fb:name></title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760188</link>
		<dc:creator><fb:name linked="false" useyou="false" uid="14700889">Nicholas Carlson</fb:name></dc:creator>
		<pubDate>Thu, 21 May 2009 22:14:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760188</guid>
		<description>Sanjay, when you&#039;re right, you&#039;re right. We&#039;ll work on that.</description>
		<content:encoded><![CDATA[<p>Sanjay, when you&#8217;re right, you&#8217;re right. We&#8217;ll work on that.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Sanjay Sharma</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760165</link>
		<dc:creator>Sanjay Sharma</dc:creator>
		<pubDate>Thu, 21 May 2009 21:59:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760165</guid>
		<description>Maybe they can use the money to increase their inventory of photos used to accompany stories.  I get sick of seeing the same pictures on their site every day.  Such is the word of Sanjay.</description>
		<content:encoded><![CDATA[<p>Maybe they can use the money to increase their inventory of photos used to accompany stories.  I get sick of seeing the same pictures on their site every day.  Such is the word of Sanjay.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Mircea @ MyTestBox.com</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760148</link>
		<dc:creator>Mircea @ MyTestBox.com</dc:creator>
		<pubDate>Thu, 21 May 2009 21:44:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760148</guid>
		<description>Ahaa...that&#039;s why they are looking now for new writers...</description>
		<content:encoded><![CDATA[<p>Ahaa&#8230;that&#8217;s why they are looking now for new writers&#8230;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: craig</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760139</link>
		<dc:creator>craig</dc:creator>
		<pubDate>Thu, 21 May 2009 21:39:49 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760139</guid>
		<description>All of us here at www.rev2.org enjoy SAI, and congratulate them in their funding!</description>
		<content:encoded><![CDATA[<p>All of us here at <a href="http://www.rev2.org" rel="nofollow"></a><a href='http://www.rev2.org'>http://www.rev2.org</a> enjoy SAI, and congratulate them in their funding!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Michael Arrington</title>
		<link>http://www.techcrunch.com/2009/05/21/another-vote-of-confidence-for-post-print-media-business-insider-raises-new-funding/comment-page-1/#comment-2760105</link>
		<dc:creator>Michael Arrington</dc:creator>
		<pubDate>Thu, 21 May 2009 21:15:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.techcrunch.com/?p=67000#comment-2760105</guid>
		<description>I love SAI, but I still think blogs raising money is absurd. 

http://www.techcrunch.com/2008/03/19/more-bloggers-raising-money-here-come-the-politics-and-here-comes-my-rant/</description>
		<content:encoded><![CDATA[<p>I love SAI, but I still think blogs raising money is absurd. </p>
<p><a href="http://www.techcrunch.com/2008/03/19/more-bloggers-raising-money-here-come-the-politics-and-here-comes-my-rant/" rel="nofollow"></a><a href='http://www.techcrunch.com/2008/03/19/more-bloggers-raising-money-here-come-the-politics-and-here-comes-my-rant/'>http://www.tech...-comes-my-rant/</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>
